Ocular Surface Disease Index
Also known as: OSDI, Ocular Surface Index
The OSDI is a 12-item symptom questionnaire designed to screen for and grade the severity of dry eye disease and other ocular surface disorders. Developed by Schiffman, Christianson, and colleagues (2000), it quantifies patient-reported ocular irritation and visual function limitations across frequency and impact domains. The OSDI is the most widely used screening tool for dry eye in clinical practice, clinical trials, and epidemiological studies worldwide.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Recommended as a screening tool at every eye examination for patients with symptoms suggestive of dry eye (irritation, blur, foreign body sensation) or risk factors (age >50, female, contact lens wear, screen use, systemic disease, medication). Repeat OSDI at 4–6 week post-intervention to assess treatment response. Essential in clinical trials of DED therapeutics. Use alongside objective tests (Schirmer, staining, osmolality) for comprehensive DED assessment, but do not rely on objective tests alone; symptom-based scoring (OSDI) takes priority in shared decision-making.
Strengths & limitations
- Highly practical: 12 items, 2–3 minute administration, no equipment required; feasible in any clinic or research setting
- Symptom-focused and functionally relevant: items address real patient concerns (reading, screen work, driving, environmental triggers), not abstract constructs
- Validated extensively: excellent internal consistency (Cronbach α 0.84–0.90), test-retest reliability (ICC >0.80), and discriminant validity (DED vs. non-DED populations)
- Responsive to treatment: OSDI improves with artificial tears, cyclosporine, warm compress, lid massage, omega-3, topical NSAIDs, and newer agents (lifitegrast, tyrosine kinase inhibitors); effect sizes large (Cohen d often >0.8)
- Internationally adopted: translated to 40+ languages, used in epidemiological studies, national surveys, and global DED registries; normative data widely available
- Symptom-only measure; does not capture objective signs (tear volume, osmolality, meibomian gland atrophy, ocular surface inflammation). A patient with low OSDI but objective evidence of DED (positive vital dye staining, high osmolality) requires clinical judgment regarding treatment.
- Moderate symptom-sign correlation: approximately 40–50% of patients with clinical DED have an OSDI score in the normal range (0–12), and vice versa (subclinical high OSDI)
- Does not distinguish cause of dry eye: OSDI is high in both aqueous-deficient and evaporative DED; additional testing required to guide targeted therapy
- Environmental and temporal influence: OSDI scores vary by season, climate, humidity, and time of day; baseline variability may reduce sensitivity to small therapeutic changes
- Limited discriminant ability in mild cases: overlap in OSDI scores between normal and mild DED (12–13 boundary) requires clinical context
Frequently asked
What OSDI score indicates dry eye disease, and what is the clinical cutoff?
OSDI >12 suggests possible DED; OSDI >23 indicates moderate DED. However, no single cutoff is diagnostic; clinical context is essential. A patient with OSDI 20 and substantial vital dye staining has DED warranting treatment. Conversely, a patient with OSDI 30 but no objective signs and normal quality of life may be managed conservatively. Always combine OSDI with objective tests and patient goals.
How much improvement in OSDI indicates treatment efficacy?
A reduction of 4 points is considered clinically meaningful (MCID). Typical improvements with effective therapy (artificial tears, cyclosporine): 5–15 point reduction over 4–12 weeks. Greater reductions (>15 points) are seen with intensive interventions (cyclosporine + punctal occlusion, meibomian gland procedures, systemic therapy).
Can OSDI be used to diagnose the type of dry eye (aqueous-deficient vs. evaporative)?
No. OSDI measures symptom severity, not etiology. Additional tests (Schirmer, meibography, tear osmolality, OCT of tear meniscus) are required to differentiate aqueous-deficient from evaporative DED. OSDI guides symptom management but not disease-specific mechanism.
Is OSDI suitable for children or contact lens wearers?
OSDI has been validated in children (age 6+) and adolescents, though most data come from adults. Contact lens wearers often have elevated OSDI due to lens-related irritation; OSDI can track improvement after lens refitting or removal. However, contact lens material and wearing time influence OSDI more than underlying DED in some patients; clinical judgment advised.
Sources
- Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D., & Reis, B. L. (2000). Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol, 118(5), 615-621. DOI: 10.1001/archopht.118.5.615 ↗
- Begley, C. G., Chalmers, R. L., Abetz, L., & Vensel, B. (2003). The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci, 44(10), 4753-4761. DOI: 10.1167/iovs.03-0270 ↗
How to cite this page
ScholarGate. (2026, June 3). Ocular Surface Disease Index. ScholarGate. https://scholargate.app/en/ophthalmology/ocular-surface-disease-index
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- IVIOphthalmology↔ compare
- LVQOLOphthalmology↔ compare
- NEI-VFQ-25Ophthalmology↔ compare
- VF-14Ophthalmology↔ compare